The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Sepsis Therapeutics Market During 2026–2030?
The sepsis therapeutics market has demonstrated substantial growth over the past few years. Forecasts show an increase from $4.39 billion in 2025 to $4.82 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. Historically, this expansion has been influenced by factors such as the limited availability of advanced sepsis therapeutics, a high prevalence of hospital-acquired infections, reliance on conventional antibiotics, growing awareness of sepsis management, and inadequate critical care infrastructure.
The sepsis therapeutics market is anticipated to show significant expansion in the upcoming years. It is projected to achieve a value of $6.92 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.5%. This increase over the forecast period is driven by the introduction of novel antibiotic classes and biologics, greater investment in sepsis research, the expansion of hospital critical care units, the implementation of advanced patient monitoring technologies, and the integration of telemedicine and digital health solutions. Notable trends for the forecast period include a rising adoption of injectable sepsis treatments, the enlargement of hospital and critical care infrastructure, the development of broad-spectrum antibiotics, an intensified focus on patient monitoring and early diagnosis, and the growth in telemedicine and remote healthcare solutions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24395&type=smp
Which Major Factors Are Driving The Expansion Of The Sepsis Therapeutics Market?
The rising occurrence of infectious diseases is anticipated to drive the expansion of the sepsis therapeutics market. Infectious diseases are conditions caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites. A key factor in this increase is climate change, which, through warmer temperatures and altered ecosystems, broadens the range of vectors such as mosquitoes that carry diseases like malaria and dengue fever. Sepsis therapeutics address infectious diseases by targeting the root infection, alleviating inflammation, and maintaining organ function to avert severe complications. For instance, as reported by the US-based National Library of Medicine in January 2023, infectious diseases are responsible for over 52 million fatalities each year, endangering half of the global population. Annually, roughly 14 million children under the age of five succumb, with 70% of these deaths being from vaccine-preventable illnesses. Consequently, the growing incidence of infectious diseases is fueling the development of the sepsis therapeutics market.
How Are The Various Segments Of The Sepsis Therapeutics Market Categorized?
The sepsis therapeutics market covered in this report is segmented –
1) By Drug Class: Cephalosporin, Aminoglycosides, Glycopeptide, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Hospitals, Clinics, Other Applications
Subsegments:
1) By Cephalosporin: First-Generation Cephalosporins, Second-Generation Cephalosporins, Third-Generation Cephalosporins, Fourth-Generation Cephalosporins, Fifth-Generation Cephalosporins
2) By Aminoglycosides: Gentamicin, Amikacin, Tobramycin, Streptomycin, Other Aminoglycosides
3) By Glycopeptide: Vancomycin, Teicoplanin, Dalbavancin, Oritavancin, Other Glycopeptides
4) By Other Drug Classes: Carbapenems, Beta-Lactamase Inhibitors, Fluoroquinolones, Macrolides, Polymyxins
What Trends Are Affecting The Expansion Of The Sepsis Therapeutics Market?
Major companies operating within the sepsis diagnostics market are prioritizing advancements in diagnostic tools, particularly through the creation of rapid molecular tests. These innovations are designed to facilitate the early and precise detection of sepsis, leading to improved patient outcomes and a reduction in mortality rates associated with delayed diagnosis. Rapid molecular tests are swift diagnostic methods that identify pathogens by detecting their genetic material using advanced techniques like PCR or isothermal amplification. As an illustration, in November 2023, Inflammatix Inc., a US-based biotechnology research company, declared the completion of technical development for its TriVerity Acute Infection and Sepsis Test System, which includes the Myrna Instrument and the TriVerity Cartridge. TriVerity is intended for deployment in emergency department settings to assess the likelihood of bacterial or viral infections and the risk of acute decompensation in patients with suspected acute infection and sepsis.
Which Major Firms Influence Developments In The Sepsis Therapeutics Market?
Major companies operating in the sepsis therapeutics market are Pfizer Inc, AstraZeneca plc, GSK plc, Eli Lilly and Company, Viatris Inc, Astellas Pharma Inc, La Jolla Pharmaceutical Company, Aridis Pharmaceuticals Inc, Partner Therapeutics Inc, InflaRx GmbH, Adrenomed AG, Sepsia Therapeutics, Endpoint Health, Prenosis Inc, Spectral Medical Inc, Modus Therapeutics, Cytovale Inc, T2 Biosystems Inc, AbbVie Inc, Merck and Co Inc
Read the full sepsis therapeutics market report here:
https://www.thebusinessresearchcompany.com/report/sepsis-therapeutics-global-market-report
Which Region Currently Holds The Largest Share Of The Sepsis Therapeutics Market?
North America was the largest region in the sepsis therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sepsis Therapeutics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24395&type=smp
Browse Through More Reports Similar to the Global Sepsis Therapeutics Market 2026, By The Business Research Company
Immune Health Supplements Market Report 2026
https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report
Anti Inflammatory Therapeutics Market Report 2026
Wound Care Biologics Market Report 2026
https://www.thebusinessresearchcompany.com/report/wound-care-biologics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model